Allogene Therapeutics Inc. logo

Allogene Therapeutics Inc. (ALLO)

Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
1. 79
0
0%
$
451.16M Market Cap
- P/E Ratio
- Div Yield
4.94M Volume
-2.03 Eps
$ 1.79
Previous Close
Add Transaction
Day Range
1.74 1.83
Year Range
0.98 4.46
Want to track ALLO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Allogene Therapeutics Inc. logo
ALLO Allogene Therapeutics Inc.
6 May 2026
-
-
Allogene Therapeutics Inc. logo
ALLO Allogene Therapeutics Inc.
4 Mar 2026
-
-
Allogene Therapeutics Inc. logo
ALLO Allogene Therapeutics Inc.
6 Nov 2025
-
-
Allogene Therapeutics Inc. logo
ALLO Allogene Therapeutics Inc.
6 Aug 2025
-
-
Allogene Therapeutics Inc. logo
ALLO Allogene Therapeutics Inc.
12 May 2025
-
-
Allogene Therapeutics Inc. logo
ALLO Allogene Therapeutics Inc.
12 Mar 2025
-
-
Allogene Therapeutics Inc. logo
ALLO Allogene Therapeutics Inc.
31 Oct 2024
-
-
Allogene Therapeutics Inc. logo
ALLO Allogene Therapeutics Inc.
31 Jul 2024
-
-
Allogene Therapeutics Inc. logo
ALLO Allogene Therapeutics Inc.
5 Jun 2024
-
-
Allogene Therapeutics Inc. logo
ALLO Allogene Therapeutics Inc.
1 May 2024
-
-
Allogene Therapeutics Inc. logo
ALLO Allogene Therapeutics Inc.
26 Feb 2024
-
-
Allogene Therapeutics Inc. logo
ALLO Allogene Therapeutics Inc.
31 Oct 2023
-
-

ALLO Earnings Reports FAQ

What is the earnings per share (EPS) for ALLO?

The current EPS is -2.03.

What is the company's earnings growth rate?

Allogene Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Allogene Therapeutics Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Allogene Therapeutics Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for ALLO at this time, as Allogene Therapeutics Inc has no recent EPS data to calculate it.